The role of mitochondrial DNA mutation on neurodegenerative diseases

Experimental and Molecular Medicine

Volumn 47, Issue 3, 2015, Pages

  Cha, Moon Yong ^a   Kim, Dong Kyu ^a   Mook Jung, Inhee ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ANIMAL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; MUTATION; NEURODEGENERATIVE DISEASES;

ANIMALS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; MUTATION; NEURODEGENERATIVE DISEASES; REACTIVE OXYGEN SPECIES;

EID: 84989336819     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2014.122     Document Type: Review

References (85)

1. Swerdlow RH, Burns JM, Khan SM. The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 2013; 1842: 1219–1231.
2. Calkins MJ, Reddy PH. Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer’s disease mice: implications for impaired mitochondrial biogenesis and synaptic damage. Biochim Biophys Acta 2011; 1812: 1182–1189.
3. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS et al. Mitochondrial abnormalities in Alzheimer’s disease.JNeurosci2001; 21: 3017–3023.
4. Gredilla R, Weissman L, Yang J-L, Bohr VA, Stevnsner T. Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer’s disease.Neurobiol Aging 2012; 33: 694–707.
5. Miquel J. An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutat Res 1992; 275: 209–216.
6. Readnower RD, Sauerbeck AD, Sullivan PG. Mitochondria, amyloid β, and Alzheimer’s disease. Int J Alzheimers Dis 2011; 2011: 104545.
7. Lezza AM, Boffoli D, Scacco S, Cantatore P, Gadaleta MN. Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochem Biophys Res Commun 1994; 205: 772–779.
8. Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 2013; 62: 90–101.
9. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787–795.
10. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. Mitochondria, oxidative stress and neurodegeneration. JNeurolSci2012; 322: 254–262.
11. Lagouge M, Larsson N-G. The role of mitochondrial DNA mutations and free radicals in disease and ageing. J Intern Med 2013; 273: 529–543.
12. Oxygen R, Nijtmans LGJ, Dieteren CEJ, Roestenberg P, Valsecchi F, Smeitink JAM et al. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 2010; 12: 1431–1470.
13. Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol 2010; 45: 466–472.
14. López-Otín C, Blasco Ma, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013; 153: 1194–1217.
15. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48: 749–762.
16. Spelbrink JN. Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges. IUBMB Life 2010; 62: 19–32.
17. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457–465.
18. Kukat C, Wurm CA, Spåhr H, Falkenberg M, Larsson N-G, Jakobs S. Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc Natl Acad Sci USA 2011; 108: 13534–13539.
19. Reeve AK, Krishnan KJ, Turnbull D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann NY Acad Sci 2008; 1147: 21–29.
20. Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood A-MJ et al. The human mitochondrial transcriptome. Cell 2011; 146: 645–658.
21. Epstein CB, Waddle JA, Hale W, Davé V, Thornton J, Macatee TL et al. Genome-wide responses to mitochondrial dysfunction. Mol Biol Cell 2001; 12: 297–308.
22. Yun J, Finkel T. Mitohormesis. Cell Metab 2014; 19: 757–766.
23. Biswas G, Anandatheerthavarada HK, Zaidi M, Avadhani NG. Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. JCell Biol 2003; 161: 507–519.
24. Finley LWS, Haigis MC. The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res Rev 2009; 8: 173–188.
25. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267–273.
26. Gomes AP, Price NL, Ling AJY, Moslehi JJ, Montgomery MK, Rajman L et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013; 155: 1624–1638.
27. Zhuang J, Wang P-Y, Huang X, Chen X, Kang J-G, Hwang PM. Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity. Proc Natl Acad Sci USA 2013; 2: 2–7.
28. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008; 9: 505–518.
29. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 2010; 11: 872–884.
30. Merz S, Westermann B. Genome-wide deletion mutant analysis reveals genes required for respiratory growth, mitochondrial genome maintenance and mitochondrial protein synthesis in Saccharomyces cerevisiae. Genome Biol 2009; 10: R95.
31. Suen D, Norris K, Youle R. Mitochondrial dynamics and apoptosis. Genes Dev 2008;: 1577–1590.
32. Brooks C, Wei Q, Feng L, Dong G, Tao Y, Mei L et al. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc Natl Acad Sci USA 2007; 104: 11649–11654.
33. Nakamura T, Lipton SA. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ 2011; 18: 1478–1486.
34. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gräber S et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006; 25: 3900–3911.
35. Byun J, Son SM, Cha M-Y, Shong M, Hwang YJ, Kim Y et al. CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer’s disease. Cell Death Differ (e-pub ahead of print 7 November 2014; doi:10.1038/cdd.2014.184).
36. Franchi L, Muñoz-Planillo R, Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012; 13: 325–332.
37. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009; 10: 241–247.
38. Lawlor KE, Vince JE. Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria? Biochim Biophys Acta 2013; 1840: 1433–1440.
39. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003; 27: 325–355.
40. Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflamma-some activation. Cell 2013; 153: 348–361.
41. Wen H, Ting JP-Y, O’Neill LAJ. A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation? Nat Immunol 2012; 13: 352–357.
42. Raturi A, Simmen T. Where the endoplasmic reticulum and the mitochon-drion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta 2013; 1833: 213–224.
43. Simmen T, Lynes EM, Gesson K, Thomas G. Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta 2010; 1798: 1465–1473.
44. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013; 495: 389–393.
45. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere J-P et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ 2012; 19: 1880–1891.
46. Iwasawa R, Mahul-Mellier A-L, Datler C, Pazarentzos E, Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J 2011; 30: 556–568.
47. Area-Gomez E, Del Carmen Lara Castillo M, Tambini MD, Guardia-Laguarta C, de Groof AJC, Madra M et al. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J 2012; 31: 4106–4123.
48. Hedskog L, Moreira C, Filadi R, Rönnbäck A, Hertwig L, Wiehager B. Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models. Proc Natl Acad Sci USA 2013; 110: 7916–7921.
49. Cha M-Y, Han S-H, Son SM, Hong H-S, Choi Y-J, Byun J et al. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 2012; 7: e34929.
50. Reddy PH. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease.Exp Neurol 2009; 218: 286–292.
51. Canugovi C, Shamanna RA, Croteau DL, Bohr VA. Base excision DNA repair levels in mitochondrial lysates of Alzheimer’s disease. Neurobiol Aging 2014; 35: 1–8.
52. Krishnan KJ, Ratnaike TE, De Gruyter HLM, Jaros E, Turnbull DM. Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease.Neurobiol Aging 2012; 33: 2210–2214.
53. Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson’s disease. Biochim Biophys Acta 2010; 1802: 29–44.
54. Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Mitochondria-targeted antioxidants for treatment of Parkinson’s disease: preclinical and clinical outcomes. Biochim Biophys Acta 2013; 1842: 1282–1294.
55. Sterky FH, Lee S, Wibom R, Olson L, Larsson N-G. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci USA 2011; 108: 12937–12942.
56. Liu W, Acín-Peréz R, Geghman KD, Manfredi G, Lu B, Li C. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc Natl Acad Sci USA 2011; 108: 12920–12924.
57. Tufi R, Gandhi S, de Castro IP, Lehmann S, Angelova PR, Dinsdale D et al. Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease. Nat Cell Biol 2014; 16: 157–166.
58. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006; 38: 518–520.
59. Pickrell AM, Pinto M, Hida A, Moraes CT. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson’s disease.JNeurosci2011; 31: 17649–17658.
60. Murakami T, Nagai M, Miyazaki K, Morimoto N, Ohta Y, Kurata T et al. Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene. Brain Res 2007; 1150: 182–189.
61. Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010; 67: 575–587.
62. Dhaliwal GK, Grewal RP. Mitochondrial DNA deletion mutation levels are elevated in ALS brains. NeuroReport 2000; 11: 2507–2509.
63. Warita H, Hayashi T, Murakami T, Manabe Y, Abe K. Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice. Brain Res Mol Brain Res 2001; 89: 147–152.
64. Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, Iwaki T. Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis. Acta Neuropathol 2002; 103: 408–414.
65. Ayala-Peña S. Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis. Free Radic Biol Med 2013; 62: 102–110.
66. Oliveira JMa, Lightowlers RN. Could successful (mitochondrial) networking help prevent Huntington’s disease?EMBO Mol Med 2010; 2: 487–489.
67. Siddiqui A, Rivera-Sánchez S, Castro Mdel R, Acevedo-Torres K, Rane A, Torres-Ramos CA et al. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington’s disease. Free Radic Biol Med 2012; 53: 1478–1488.
68. Wang J-Q, Chen Q, Wang X, Wang Q-C, Wang Y, Cheng H-P et al. Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease. JBiol Chem 2013; 288: 3070–3084.
69. Segref A, Kevei E, Pokrzywa W, Schmeisser K, Mansfeld J, Livnat-Levanon N et al. Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome system. Cell Metab 2014; 19: 642–652.
70. Andreux Pa, Houtkooper RH, Auwerx J. Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov 2013; 12: 465–483.
71. Okamoto K. Mitochondria breathe for autophagy. EMBO J 2011; 30: 2095–2096.
72. Nakahira K, Haspel JA, Rathinam VAK, Lee S-J, Dolinay T, Lam HC et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12: 222–230.
73. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333: 1109–1112.
74. Kurihara Y, Kanki T, Aoki Y, Hirota Y, Saigusa T, Uchiumi T et al. Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J Biol Chem 2012; 287: 3265–3272.
75. Smith RaJ, Hartley RC, Cochemé HM, Murphy MP. Mitochondrial pharma-cology. Trends Pharmacol Sci 2012; 33: 341–352.
76. Dai D-F, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res 2012; 110: 1109–1124.
77. Murphy MP, Smith RAJ. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007; 47: 629–656.
78. McManus MJ, Murphy MP, Franklin JL. The mitochondria-targeted anti-oxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease. J Neurosci 2011; 31: 15703–15715.
79. Rodriguez-Cuenca S, Cochemé HM, Logan A, Abakumova I, Prime TA, Rose C et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 2010; 48: 161–172.
80. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP et al. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer’s disease neurons. J Alzheimers Dis 2010; 20(Suppl 2): S609–S631.
81. Tonin Y, Heckel A-M, Vysokikh M, Dovydenko I, Meschaninova M, Rotig A et al. Modelling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mtDNA. JBiolChem2014; 289: 13323–13334.
82. Gammage PA, Rorbach J, Vincent AI, Rebar EJ, Minczuk M. Mitochond-rially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med 2014; 6: 1509–1639.
83. Kim S-J, Cheresh P, Williams D, Cheng Y, Ridge K, Schumacker PT et al. Mitochondria-targeted Ogg1 and aconitase-2 prevent oxidant-induced mitochondrial DNA damage in alveolar epithelial cells. J Biol Chem 2014; 289: 6165–6176.
84. Bacman SR, Williams SL, Pinto M, Peralta S, Moraes CT. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med 2013; 19: 1111–1113.
85. Heddi A, Stepien G, Benke PJ, Wallace DC. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. JBiolChem 1999; 274: 22968–22976.